Objective-To examine the eVect of iron on the prostaglandin (PG) E 2 production by human synovial fibroblasts in vitro. Methods-Human synovial fibroblasts were isolated from synovial tissue of rheumatoid arthritis (RA) and osteoarthritis (OA) patients and cultured in medium. Synovial fibroblasts were stimulated by human recombinant interleukin (IL) 1 (0.1-10 ng/ml) with or without ferric citrate (Fe-citrate, 0.01-1 mM). The amount of PGE 2 in the culture medium was measured by an enzyme linked immunosorbent assay. Results-The production of PGE 2 by the synovial fibroblasts was increased by stimulation with IL1 at all concentrations tested. Fe-citrate but not sodium citrate (Na-citrate) down regulated the production of PGE 2 by the synovial fibroblasts, both with and without stimulation by IL1 . Fe-citrate inhibited the spontaneous PGE 2 production by the cells in a dose dependent manner, and a maximum inhibition by Fe-citrate was observed at the concentration of 0.1 mM with IL1 stimulation. The down regulation by iron was reversed by the co-addition of desferrioxamine (100 µg/ml), an iron chelator. Conclusion-Iron down regulates the PGE 2 production by synovial fibroblasts in vitro.
Since Muirden and Senator reported the deposition of iron in synovial tissue in rheumatoid arthritis (RA) patients, 1 the roles of iron in joint inflammation have been discussed extensively.
2 For example, iron catalyses oxidative radical reactions (Haber-Weiss reaction), which lead to the formation of the most toxic hydroxyl radical and subsequent lipid peroxidation and tissue damage.
2 Iron also changes the lymphocyte migration to the joint and modulates T cell surface molecule expression, 3 macrophage phagocytic function, 4 and natural killer cell activity. 5 Synovial cell proliferation is a major pathological finding in RA synovia. 6 We previously reported that iron by itself stimulated DNA synthesis by human synovial cells and did so synergistically with cytokines such as interleukin (IL)1 , IL7, and tumour necrosis factor (TNF) in vitro. 7 Prostaglandin E 2 (PGE 2 ) is widely considered to have an important role in the inflammatory process in rheumatoid joints. PGE 2 has been demonstrated to be an important mediator of vascular permeability, hyperalgesia, and IL6 production in vivo, with the use of a neutralising anti-PGE 2 monoclonal antibody. 8 Furthermore, the eVect of PGE 2 on the developement of oedema and pain is shown by the marked therapeutic eVect of nonsteroidal anti-inflammatory drugs (NSAIDs), inhibitors of the production of prostaglandin metabolites. 8 PGE 2 is also known to have a suppressive eVect (as an internal regulator) on fibroblast proliferation in human dermal fibroblasts 9 and IL1 production in murine peritoneal macrophages. 10 In this study, we examined the eVect of iron on the PGE 2 production by human synovial fibroblasts in vitro, and we found that iron may stimulate synovial fibroblast proliferation by down regulating PGE 2 production.
Methods

CULTURE OF SYNOVIAL FIBROBLASTS
Synovial tissues were obtained from 16 patients, eight with RA and eight with osteoarthritis (OA) who underwent total knee replacement surgery. All of the RA patients were women (age range 46 to 74, average: 63.4 years) who were at stage IV and class III. The eight patients with OA consisted of two men and six women, age range 66 to 77, average: 70.9 years. The synovial fibroblasts were isolated according to the method previously described. 7 Immediately after surgery, the patients' synovial tissues were placed in plastic Petri dishes (Falcon No3003AJ, 100 × 20 mm, Becton Dickinson Co, Lincoln Park, NY, USA) containing Hanks's balanced salt solution (HBSS, GIBCO Labs, Life Technologies Inc, Grand Island, NY, USA) without Ca ++ and Mg ++ , and minced with scissors. The tissues in HBSS were incubated with collagenase (200 u/ml, Worthington Biomedical Co, Freehold, NJ, USA) and DNase (25 µg/ml, Sigma Chemical Company, St Louis, MO, USA) with stirring for one hour at 37°C. The tissue solution was then passed through a layer of iron mesh. The cells were washed three times in Dulbecco's modified Eagle medium (DMEM, GIBCO). The cells (1 × 10 6 /ml) were then resuspended in DMEM, which was supplemented with penicillin G (100 IU/ml), streptomycin (100 µg/ml), amphotericin (2 µg/ml, Squibb Co, Tokyo, Japan), and 10% fetal bovine serum (FBS, heat inactivated, GIBCO) and incubated in Petri dishes at 37°C in a 5% carbon dioxide incubator. When the cultured cells reached confluence in a single layer, they were detached with a solution containing one volume of trypsin (0.5 mg/ml, GIBCO Labs) and four volumes of EDTA (0.2 mg/ml, Dojindo, Kumamoto, Japan) and glucose (0.2 mg/ml, Nakarai Co, Kyoto, Japan), in phosphate buVered saline (0.1 M, pH 7.2). The detached cells were washed three times with DMEM and resuspended in DMEM with 10% FBS (2 × 10 4 /ml in a turtle shaped culture bottle, Falcon No 3013) to continue the culture. The material containing the synovial fibroblasts during the 3rd to 7th passage was used in the experiments.
PRODUCTION OF PGE 2
Synovial fibroblasts at two diVerent cell concentrations, namely 1 × 10 4 and 1 × 10 5 cells/well, were added to each well of a 24 well macroplate (Falcon No 3047), and were cultured for 18, 24, 48, and 72 hours. After incubation for various periods, the supernatants were centrifuged at 1500 rpm for five minutes and stored at −20°C until required for the measurement of PGE 2 . PGE 2 in the culture supernatant was measured by a commercially available enzyme linked immunosorbent assay (ELISA) kit (Cayman Chemical Co, Ann Arbor, MI, USA).
IRON SALTS
Ferric citrate (Fe-citrate, Sigma Co) or sodium citrate (Na-citrate, Ishizu Co, Osaka, Japan) was dissolved in HBSS (GIBCO) and adjusted to pH 7.2 with 1N HCl or 1N NaOH as described. 7 The iron concentration in the 0.1 mM Fe citrate solution was 620 µg/dl. 7 This in vitro iron concentration is comparable to the in vivo serum iron concentrations in patients with iron overload and the concentration of iron in synovial membrane from patients with RA. Desferrioxamine (DFX), an iron chelating agent was perchased from CIBA-GEIGY Ltd, Takarazuka, Japan.
CULTURE OF SYNOVIAL FIBROBLASTS WITH IRON OR SODIUM
Synovial fibroblasts (1 × 10 4 cells/well), suspended in DMEM with 10% FBS, were cultured for 48 hours with 0.1 mM Fe-citrate or 0.1 mM Na-citrate in the presence or absence of various concentrations of recombinant human IL1 supplied by Otsuka Pharmaceutical Co (Tokushima, Japan). For the other experiments, various concentrations of Fe-citrate were added to synovial fibroblast cultures.
STATISTICAL ANALYSIS
The diVerences in PGE 2 production by synovial fibroblasts cultured with Fe-citrate compared with Na-citrate or medium alone were analysed with paired Student's t test. A level of p < 0.05 was accepted as significant.
Results
SPONTANEOUS PGE 2 PRODUCTION BY SYNOVIAL
FIBROBLASTS
In a time course study, it was shown from four diVerent experiments that the spontaneous PGE 2 production by synovial fibroblasts in culture medium reached a plateu after 24-48 hours of incubation at two diVerent cell concentrations (mean (SEM) 1929 (256) pg/ml in 1 × 10 4 cells/well and 5831 (2005) pg/ml in 1 × 10 5 cells/well). From these results, the culture supernatants for the assay were collected after 48 hours of incubation at the cell number of 1 × 10 4 cells/well. IL1 significantly increased the PGE 2 production by synovial fibroblasts after a 48 hour incubation at all concentrations tested (0.1 ng/ml: mean (SEM) 9544 (2139) pg/ml (n=6 ), 1 ng/ml: 11 107 (3025 pg/ml, 10 ng/ml: 11 896 (3169) pg/ml) compared with the value of 1400 (474) pg/ml without IL1 . Fe-citrate at the concentration of 0.1 mM but not Na-citrate downregulated the PGE 2 production by synovial fibroblasts, both with and without stimulation by IL1 (fig 1) . In a second set of experiments, we examined the eVect of diVerent concentrations of Fecitrate on the PGE 2 production by synovial fibroblasts in a time course study. Fe-citrate significantly suppressed the PGE 2 production without stimulation by IL1 , in a dose dependent manner (fig 2A) . The stimulation by IL1 (1 ng/ml) increased the PGE 2 production by synovial fibroblasts by about fivefold or sixfold in comparison with the values of spontaneous production at all incubation times examined (24, 48, and 72 hours) (fig 2A and  2B) . The maximum inhibition by Fe-citrate of the PGE 2 production was obtained at the concentration of 0.1 mM after 24 or 48 hours with the stimulation by IL1 (fig 2B) .
No diVerence in PGE 2 production in response to iron treatment was observed using the cells derived from either RA or OA patients.
EFFECT OF DESFERRIOXAMINE (DFX) ON THE FE INDUCED DOWNREGULATION OF PGE 2 PRODUCTION BY SYNOVIAL FIBROBLASTS
Desferrioxamine (DFX), an iron chelating agent, at the concentrations of 1, 10, and 100 µg/ml was added to the synovial fibroblast culture system with or without Fe-citrate (0.1 mM) and IL1 (1 ng/ml). DFX at 100 µg/ml completely inhibited the down regulatory action of Fe-citrate on the PGE 2 production by synovial fibroblasts (table 1) . DFX at the highest concentration tested significantly increased the spontaneous PGE 2 production by synovial fibroblasts. The same tendency by DFX was also observed in IL1 stimulation (table 1) . 
Discussion
It was shown in this study that iron in the form of ferric citrate (Fe-citrate) suppressed the PGE 2 production by human synovial fibroblasts in vitro. In contrast, Okazaki et al reported that iron in the form of ferric nitrilotriacetate (Fe-NTA) increased the PGE 2 production by rabbit synovial fibroblasts. 11 This discrepancy might be derived from (1) the diVerent forms of iron salts used; Fe-citrate is physiological and Fe-NTA is carcinogenic, and (2) the cells used are from diVerent species (human and rabbit synovial fibroblasts). Iron is present in the rheumatoid synovial tissue mainly in the form of ferritin, iron storage protein or Perl positive stainable iron as haemosiderin. Each of these forms might be able to release iron to form hydroxyl radicals. 2 12 Moreover, iron exists in the form of citrate as non-transferrin bound iron, one of the low molecular weight chelators in RA synovia, being a donor for iron in the Haber-Weiss reaction. Interestingly, it was recently demonstrated that K562 cells, an erythroid leukaemia cell line, have two iron transport systems: (1) the classic transferrin (Tf) mediated iron uptake via the Tf receptors, and (2) a non-Tf (commonly citrate) pathway via cell surface integrin. 13 Human synovial fibroblasts may also utilise the non-Tf pathway to take up iron for their proliferation, as described in our previous report. 7 PGE 2 , the major arachidonic metabolite, is a potent mediator of pain and oedema at sites of inflammation. 8 In addition, PGE 2 has many immunoregulatory functions including the inhibitions of Ia expression, the IL1 and TNF production by macrophages and antigen induced T cell proliferation, and the promotion of the diVerentiation of suppressor T cells and immunoglobulin secreting cells.
14 PGE 2 plays a part as an internal regulator of the growth of fibroblasts 9 and of IL1 production in macrophages. 10 Our results demonstrate that iron downregulates the PGE 2 production by human synovial fibroblasts in culture, although the possibility that iron stimulates PGE 2 metabolism remains. This indicates that the stimulation of synovial fibroblast DNA synthesis by iron 7 might be caused by the suppression of PGE 2 production. 9 10 The concentration of 0.1 mM Fe-citrate was most eVective in the suppression of PGE 2 production ( fig 2B) . This phenomenon was also observed in the stimulation of synovial fibroblast DNA synthesis 7 and the modulation of cell surface molecule expression, 3 which may also support the above mentioned mechanism.
Prostanoid production including PGE 2 is mediated through cyclooxygenase (COX), a classic heme peroxidase in the prostaglandin cascade. 15 There are two isoforms of COX. COX I is constitutively expressed in most tissues, and COX II is inducible by various proinflammatory agents including IL1 . 15 Iron may suppress the PGE 2 production by directly influencing the activity, protein synthesis or mRNA expression of COX. Salvemini et al demonstrated that nitric oxide (NO) increase PGE 2 production via the activation of COX activity in a mouse macrophage cell line. 16 Weiss et al reported that iron suppresses the NO production of a murine macrophage cell line by decreasing NO synthase activity. 17 Thus, iron may downregulate PGE 2 production indirectly by decreasing the NO production via suppressed NO synthase activity.
The synovitis caused by the actions of PGE 2 8 may be diminished by the down regulation by iron of PGE 2 production. Agro et al recently demonstrated that PGE 2 increases IL6 and IL8 but not granulocyte macrophage colony stimulating factor (GM-CSF) production in human synovial fibroblasts. 18 Thus, the production of IL6, one of the most potent inflammatory mediators 8 could be decreased by iron through the suppressed production of PGE 2 , which is an enhancer of IL6 production. 18 However, IL6 has the ability to increase the production of tissue inhibitor of matrix metalloproteinase, which is involved in the restoration of tissue at the site of inflammation. 19 From this aspect, iron may delay the tissue reconstruction after inflammation by decreasing the IL6 production. Thus, iron does not necessarily work in the anti-inflammatory direction only by suppressing PGE 2 production. In fact, tetradecanoyl phorbol acetate induced inflammation still occurs in the COX-II gene knock out mice without PGE 2 . 20 In addition, PGE 2 inhibits the rheumatoid factor production by B cells from RA patients.
14 Rheumatoid factor production could be increased by the suppression of PGE 2 production. Taken together, these findings indicate that down regulation of PGE 2 production by iron could increase the chronic inflammation in RA joints. 
